Billionaire Cliff Asness’ Top 10 Healthcare Stock Picks
Cliff Asness is a billionaire investor and the co-founder and chief investment officer of AQR Capital Management, a quantitative hedge fund.
Merck & Co. Inc. (MRK)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ayrshire Capital Management John Nevin Jr. | 1,719 | $220,881 | +2% | 0.1% |
| 2. | Zevenbergen Capital Investments Nancy Zevenbergen | 1,565 | $201,103 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $88.25 | 2,833 | $249,999.98 | 2,933 | 2025-02-06 | Filing | |
| $88.50 | 15,000 | $1,327,500.00 | 16,000 | 2025-02-05 | Filing | |
| $113.68 | 3 | $341.04 | 20,599 | 2023-04-26 | Filing | |
| $105.47 | 136 | $14,343.92 | 20,631 | 2023-03-20 | Filing | |
| $109.20 | 11 | $1,201.20 | 20,495 | 2023-02-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $121.46 | 10,000 | $1,214,562.00 | 60,615 | 2026-02-12 | Filing | |
| $117.52 | 10,235 | $1,202,843.81 | 92,035 | 2026-02-10 | Filing | |
| $118.41 | 10,000 | $1,184,101.00 | 70,615 | 2026-02-09 | Filing | |
| $119.15 | 38,835 | $4,627,275.69 | 68,916 | 2026-02-09 | Filing | |
| $119.15 | 56,792 | $6,766,891.74 | 68,916 | 2026-02-09 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,360,649 | $817,343,408 | 0.7% | |
| 2. | 2,702,992 | $347,334,472 | 0.43% | |
| 3. | 1,625,531 | $183,546,956 | 0.31% | |
| 4. | 1,169,722 | $150,309,277 | 1.6% | |
| 5. | 736,662 | $94,661,092 | 1.11% |
News See All
10 Reliable Dividend Stocks to Buy for Long-Term Investors
Dividend stocks have long been a favorite among investors focused on building wealth over time.
Is Merck & Co., Inc. (MRK) Strengthening Its Vaccine Portfolio With New Capvaxive Approval?
TheFly reported on June 18 that MRK announced that the U.S.
10 Best Weight Loss Drug Stocks to Buy in 2026
The anti-obesity drug (AOM) market in the United States is rapidly changing structurally.
Kevin O'leary's Stock Portfolio: Top 10 Stock Picks for 2026
Kevin O’Leary’s public investing persona has long leaned toward businesses with cash generation, shareholder returns, and financial discipline rather than high-risk growth stories.
10 Undervalued Counter Cyclical Stocks to Buy Now
Counter-cyclical stocks are getting more attention as investors look for businesses tied to demand that does not disappear just because the economy slows.
Billionaire Ken Fisher’s Top 11 Dividend Stock Picks
In a recent episode of the Market Insights podcast, Fisher Investments Founder, Executive Chairman, and Co-Chief Investment Officer Ken Fisher addressed a new set of listener questions.
Is Merck & Co. (MRK) One of the Best Cheap Stocks to Buy for Beginners?
Merck & Co., Inc. (NYSE:MRK) is one of the best cheap stocks to buy for beginners. Moderna, Inc. and Merck & Co., Inc.
Merck & Co. (MRK) Announces Quarterly Dividend
Merck & Co., Inc. (NYSE:MRK) is one of the best inexpensive stocks to invest in right now. Merck & Co., Inc.
Hedge Fund Resource Center